Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
2021 CMTA Annual Report
Ways to Give
FUND CMT RESEARCH The Strategy to Accelerate Research (STAR) incorporates a strategic approach to funding cutting edge research. LEARN MORE ABOUT GIVING TO CUTTING EDGE RESEARCH Be part of the…
2018_CMTA_Annual_Report
CMTAreportSummer2022web
2018_Summer_CMTA_Report
2018_Summer_CMTA_Report
CMTAreportSummer2022web
Progress Update: Timmerman’s CMT1A Organoid Project Shows Early Success
…stay current on this and all other CMT research and CMTA news. Create Your Patients as Partners in Research Profile Sign up for CMTA eNews Published On: October 29, 2024…
CMTA’s $450K Investment Targets New Approach to Treatment for Patients with CMT1A and CMT1B
The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth (CMT) disease research aimed at bringing treatments to patients, announced today an investment of $450K into a new scientific approach…
CMTA Announces Strategic Partnership with Acceleron to Advance CMT Treatment Options
…developing medicines to treat serious and rare diseases, including CMT. The CMTA’s Strategy to Accelerate Research (STAR) connects top CMT clinicians and academic researchers with pharmaceutical partners committed to developing…